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ABSTRACT 
Migraine and Psychopathology: 
An Analysis by Migraine Subtype 
Geraldine Teresa Mogavero 
1988 
This study investigates the relationship between migraine 
and psychopathology in a sample of subjects in treatment for 
migraine. Several domains of psychopathology were assessed 
including psychiatric diagnoses, personality, temperament and 
social functioning. Seventy one migraine patients were 
interviewed using a standardized diagnostic interview, the 
Schedule for Affective Disorders and Schizophrenia, and the 
Migraine Symptom Review. The lifetime prevalence of depression 
among subjects with migraine was 60%. Rates of anxiety 
disorders, notably panic disorder and phobic conditions, were 
also highly elevated. However, there was no difference in 
lifetime prevalence of psychopathology between various subtypes 
of migraine including the "classic" vs. "common" distinction or 
"menstrual migraine." "Menstrual migraine," though, was 
associated with less severe headaches and greater family history 
of migraine. 
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They seemed to be selfish, these headaches, and 
yet they were not. The pain was real. No one could 
simulate such agonizing pain. Mr. Pritchard 
dreaded them more than anything in the world. A 
good one could make the whole house vibrate with 
horror.(1) 
Migraine headaches were initially described by Aretaeus of 
Capadocia during the 1st century A.D.(2) Despite the vast amount 
of medical knowledge accrued during the intervening centuries, 
migraine headaches remain an enigma to both neurologist and 
psychiatrist. 
Current definitions of migraine headaches are based on 
proposals by the Ad Hoc Committee on the Classification of 
Headache in 1962. This committee, formed by the National 
Institute of Neurological Diseases and Blindness, divided the 
broad term "headache" into fifteen varieties.(3) "Vascular 
headaches of the migraine type" were recurring headaches, often 
unilateral and accompanied by anorexia, nausea and vomiting. 
They ranged in severity, duration and frequency, and were 
sometimes preceded by sensory, motor and mood alterations. 
Migraines were also noted to have a familial preponderance.(4) 
"Muscle-Contraction headache," the second major class of 
headaches, was typified by a constricting pain or pressure caused 
by skeletal muscle contraction. Although the sensations could be 
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long-lasting, no associated permanent alteration in structure was 
noted.(4) Pain was most often described as non-pulsatile, 
distributed bilaterally in occipital, facial, and frontal, or 
"hat-band" regions.(3) Onset of pain was usually related to 
exacerbation of life stress.(4) 
New criteria for migraine headache are currently being 
developed and are likely to circulate in the spring of 1988. 
The major difference between the new and current definition 
involves the addition of periodicity of migraines to further 
differentiate them from tension headaches and temporal-mandibular 
joint syndrome. In order to be classified as having migraine, 
the patient must experience headache-free periods, have no more 
than a specific number of headache episodes per year 
(approximately 12), and each headache must not last greater than 
24 hours.(5) 
The wide disparity of migraine definitions is partially 
attributable to the lack of objective diagnostic tests for 
migraine. Therefore, information regarding migraine is derived 
from a clinical interview based upon the subject's description of 
symptoms. A similar situation pertains to psychiatric diagnosis 
as well. According to Robins and Guze (6), there are five phases 
necessary to establish a valid psychiatric classification, and 
these criteria can be extended to apply to diagnoses in 
medicine. The first phase is clinical description. Clinical 
description comprises not only the symptomatology but also the 
epidemiology which distinguishes one disorder from all others. 
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Migraine literature abounds with careful portrayals of the 
clinical features of migraine as well as broad community studies 
to delineate the epidemiologic parameters of the affected 
population. 
The second factor necessary for a valid diagnostic category 
is delimitation from other disorders. In order to study a 
specific disorder, the probands should be clinically homogeneous; 
subjects with other disorders with similar clinical 
manifestations to that under study should be carefully excluded. 
With migraine, the diagnosis may be one of exclusion, following 
diagnostic tests to rule out diseases with overlapping symptoms. 
One advantage to utilizing patients in treatment for migraine to 
study the illness is that most doubtful cases will therefore be 
excluded from the group. The third phase, that of laboratory 
study, is less adequately established for migraine. Research to 
explain the pathophysiology of migraine remains inconclusive, and 
there are no chemical, radiological or anatomical findings to 
separate migraine from other headaches. The fourth and fifth 
phases are follow-up study and family study. The former 
establishes that over time, the patients do not have widely 
disparate outcomes or develop another disorder which could have 
caused the migraine-like manifestations. The latter proposes 
that since many diseases run in families, showing increased rates 
of migraine in a proband's relatives helps confirm diagnostic 
validity. 
The following discussion of migraine is loosely structured 

4 
along the five diagnostic phases described by Robins and Guze.(6) 
The literature involving the first three steps toward 
establishing a valid diagnostic category for migraine--clinical 
description, delimitation from other disorders and laboratory 
study--is reviewed in three separate sections. The last two 
phases--follow-up and family studies--are included in the broader 
category of epidemiology. Additionally, specific aspects of 
migraine, psychopathology, endocrinology and their 
interrelationship will be explored in detail. 
Clinical Description and Classification 
Most researchers divide migraine headaches into "classic" 
and "common" varieties. The "classic" sub-type accounts for 10% 
to 15% of all patients with migraine.(7,8) A sharply-delineated 
prodrome usually precedes the actual headache by approximately 
twenty minutes and resolves with the onset of pain.(8) The 
neurologic manifestations of the prodrome include visual, motor 
and sensory disturbances.(4) Visual auras predominate, 
characteristically with a scintillating scotoma or "fortification 
spectrum." A central or paracentral cluster of strobing-neon, 
zig-zag lines coallescing into a serrated shape resembling a 
fort's embattlements slowly travels across the visual field. The 
scotoma enlarges and distorts as it moves toward the edges of the 
visual field, and eventually disappears. (8,9 ) The headache phase 
of "classic" migraine is typified by unilateral, pulsatile pain. 
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photophobia, and alimentary disturbances such as anorexia, nausea 
and vomiting.(7,10) 
Although the "common" and "classic" variants of migraine 
share much of the same symptomatology, the prodromes of "common" 
migraine are less well-defined, often preceding the actual 
headache by hours or days.(7) These "common" migraine prodromes, 
often comprised only of mood changes such as depression, elation 
or irritability, may only precede the headache phase 25% of the 
time.(11) The actual headache of the "common" type is less 
likely to be unilateral than in "classic" migraine and often 
lasts longer than the headache of "classic" migraine.(7) The Ad 
Hoc Committee noted the relationship of "common" migraine to 
alterations in the environment, occupational exposure and 
menstruation. Reflecting these associations, "common" migraine 
has often been referred to as "atypical migraine" or "sick 
headache."(4) 
These two major divisions of migraine are not mutually 
exclusive, however. An individual with a past history of 
"classic" migraine may present with "common" migraine, or even a 
headache with features of both. Most migraine sufferers also 
have experienced muscle-contraction headaches, further confusing 
classification attempts.(7) 
Delimitation from Other Disorders 
When vascular headaches were first elucidated. cluster" 
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headaches and migraine were described as differing manifestations 
of the same entity. "Cluster" headaches consist of unilateral 
facial or head pain of brief duration occurring at least once per 
day over the course of weeks or months. These intense headaches, 
lasting less than two hours, remit for long periods of time only 
to recur with equal furor. Lacrimation, rhinorrhea and 
conjunctival injection frequently accompany the headache. Twenty 
percent also demonstrate an ipsilateral Horner's Syndrome, 
ptosis, miosis, enopthalmus and anhidrosis.(4,5) 
Recently, however, most scientists have concluded that 
"cluster" headaches and migraine are two separate classes of 
headache. "Cluster" headaches occur more commonly in males, 
demonstrate different serum levels of histamine and serotonin, 
and have a disparate time course and frequency than migraine.(9) 
"Cluster" headaches, therefore, have been excluded from most 
current migraine research. 
One additional form of vascular event, recently described as 
"late-life migraine" closely simulates a transient ischemic 
attack and appears in a separate epidemiologic pattern from other 
varieties of migraine. Patients tend to be 50 to 60 years of age 
and 35% have had no previous migraine headaches. Symptoms 
consist of migrainous manifestations such as scintillating 
scotomas and paresthesias, but 60% have no associated headache. 
These symptoms last approximately 15 to 20 minutes, and the re¬ 
occurrence of identical episodes helps to rule out an embolic 
etiology. "Late-life migraine is a diagnosis of exclusion 
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following normal angiography and results in no permanent 
neurologic deficits.(12) The relationship of "late-life 
migraine" to "common" and "classic" migraine is unknown, and 
therefore these patients are not usually considered as part of 
the group of migraineurs. 
Other syndromes mimic migraine symptomatology and must be 
considered as part of the differential diagnosis. Cerebral 
ischemia, tumor and epilepsy may present with neurologic 
manifestations similar to those of migraine. More obscure 
diseases such as pheochromocytoma and temporal arteritis have 
also been mistakenly classified as migraine.(7) These 
potentially fatal illnesses have been recognized as possible 
etiologies of migraine-like symptoms and are carefully excluded 
prior to designating a patient as a migraineur. 
Epidemiology 
Researchers estimate that 4-19% of adult men and 8-29% of 
adult women suffer from some form of migraine headache.(13,14) 
In absolute terms, the National Migraine Foundation states that 
there are 12 million migraine sufferers in the United States 
alone. Less than 50% of these seek medical assistance, 
resulting in a patient self-selection bias for the more severe 
clinical manifestations.(14) The onset of migraine headaches may 
occur from the childhood years through adulthood (7), with the 
mean age of onset between 5 and 11 years of age.(14) Selby and 
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Lance documented first episodes of migraine occurring as early as 
18 months of age and as late as 60 years of age.(15) Lifetime 
prevalence of migraine increases with age, peaking in males 
during the fourth decade and in females during the late fourth or 
fifth decade of life.(10) Ninety-two percent of the 496 patients 
evaluated by Selby and Lance had onset of migraine headaches 
prior to age 40, with 21% prior to age 10.(15) 
Childhood migraine, however, may be underestimated due to 
misdiagnosis. Many children who later manifest the complete 
migraine syndrome present earlier with gastrointestinal and 
neurologic precursors without head pain. Motion sickness, cyclic 
vomiting, unilateral paralysis and visual symptoms have all been 
correlated with future migraine onset.(7,8) Migraine has even 
been missed in younger patients complaining of headache. A 
recent JAMA article reported that adolescent females may be 
accused of alcohol or drug abuse when in reality they have a 
migraine varient involving the basilar artery. The patient 
appears intoxicated, with dizziness, dysarthria and blurred 
vision.(8) MacDonald evaluated 421 children under the age of 15 
who presented to an outpatient clinic with headache.(16) 
Although tumors, seizures, depression and tension headache were 
eventually diagnosed in some patients, the majority were 
classified as migraineurs. 
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Table 1. Diagnosis in 421 Children with Headache (16) 
Diagnosis Male Female 
N <y /o N % 
Migraine Headache 
Classic 54 (24. .3) 39 (19. .6) 
Common 85 (38. .3) 66 (33 . 2) 
Hemiplegic 8 ( 3. .6) 6 ( 3 . 0) 
Ophthaloplegic 1 ( o. .5) 0 ( 0. .0) 
Basilar Artery 7 ( 3. .2) 9 ( 4. .5) 
Acute Confusional State 2 ( o. ■9) 0 ( 0. .0) 
+ Tension Headache 20 ( 9. .0) 24 (12. 1) 
+ Seizures 5 ( 2. .3) 6 ( 3 . 0) 
Tension Headache 19 ( 8. .6) 26 (13. ■1) 
Depression 2 ( o. •9) 8 ( 4. .0) 
Seizures 6 ( 2. •7) 9 ( 4. .5) 
CNS Tumor 3 ( 1. .4) 1 ( 0. .5) 
CNS Vascular Malformation 1 ( o. .5) 1 ( 0. .5) 
Other 9 ( 4. .1) 4 ( 2 . 0) 
Total 222 199 
As suggested by MacDonald's study, the pre-pubertal 
incidence of migraine is similar for both sexes.(17) At some 
point during the second to early third decades, however, migraine 
incidence demonstrates a difference between the sexes.(14) (see 
Table 2) As many as four to eight times the number of adult 
females as compared to adult males may experience migraine 
headaches.(17) 
Table 2. Lifetime Prevalence of Migraine in Schoolchildren (18) 
Age (years) Migraine (%) 
Boys Girls 
7 1. 1 1.7 
8 2.7 2.7 
9 3.5 2.9 
10 4.0 3.3 
11 3.7 5.7 
12 3.5 6.9 
13 4.0 5.9 
14 5.4 4.8 
15 1.5 8.2 
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Although careful epidemiologic study verifies the female 
preponderance in migraineurs, correlations with intelligence and 
socio-economic status have not withstood similar tests.(13) 
Waters (19,20) and Bille (18) reached separate, but similar, 
conclusions following community studies of adults and children 
with migraine. The increased prevalence of highly intelligent, 
professional, middle and upper class migraine patients reflects a 
self-selection or investigator bias. Migraine sufferers with 
these characteristics are more likely to obtain medical help than 
their lesser educated and poorer counterparts. 
Twin studies have also been an invaluable epidemiologic tool 
for evaluating possible genetic or familial influences in 
migraine. Although controlling for environmental influences 
remains difficult, increased concordance ratios of migraine in 
monozygotic versus dizygotic twins implies a role for genetic 
transmission in migraine.(14) Lucas (21) evaluated 1300 twins 
registered by the Institute of Psychiatry in London and concluded 
that both twins had migraines in 26% of monozygotic pairs and 13% 
of dizygotic pairs. This statistically significant difference 
supported earlier studies by Harvald and Hauge (22), and Ziegler 
et al. (23) stating zygosity disparities of 33% versus 5.3% and 
22% versus 7%, respectively. 
Pathophysiology and Laboratory Study 
Whereas most researchers agree that migraine headaches are 
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genetically influenced, the pathophysiology of migraine remains a 
hotly debated issue. There have been two major hypotheses 
advanced, and neither irrefutably proven. Both the vascular and 
neural theories retain broad-based support, and many believe that 
the true pathophysiology contains elements from each. 
One of the earlier proponents of the vascular theory was 
Harold G. Wolff, Chairman of the Department of Neurology at 
Cornell Medical School. During the 1930's and 40's, Wolff 
induced migraines in patients during craniectomy and noted the 
resultant hyperemia. He also observed that the migraine- 
associated visual disturbances ceased when patients inhaled a 
potent vasodilator, such as amyl nitrate.(9) Combining these 
results, Wolff concluded that intracerebral vasoconstriction 
caused the preceding aura of migraine and triggered extracranial 
vasodilatation which corresponded to the headache phase.(9) 
Since Wolff put forth the vascular theory of migraine 
headache, his original ideas have been embellished, but the 
concept remains essentially unchanged. The migraine cycle 
commences with a rise in plasma norepinephrine. Increased 
norepinephrine leads to platelet aggregation. The platelets, in 
turn, release serotonin and ADP, causing additional platelet 
aggregation, arterial constriction and capillary dilatation. The 
decreased blood flow and cerebral ischemia due to arterial 
constriction result in the prodromal aura of neurologic and 
visual disturbances.(8,9) 
In addition to serotonin, aggregated platelets also release 
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neurokinins. These sensitize pain receptors in extracranial 
vessel walls, accounting for the scalp and neck tenderness which 
often accompanies migraine headaches.(8,9) Plasma serotonin 
levels eventually decrease through uptake by perivascular tissue 
and blood vessels. Arteries then dilate, and the already 
sensitized blood vessel walls cause the headache phase of the 
migraine attack.(8,9) 
Supporters of the vascular hypothesis cite the pulsatile 
quality of the headache as well as the relief of symptoms 
following internal carotid artery compression as proof of Wolff's 
theory.(9) Migraine head pain also appears to follow the course 
of the external carotid artery, and not the trigeminal nerve. 
The prodromal aura, purportedly caused by cerebral 
vasoconstriction, is lengthened by alpha agonists such as ergot, 
and shortened by vasodilators such as nitrates. The painful 
vasodilatation phase, on the other hand, is relieved by ergot and 
exaccerbated by nitrates.(24) 
The vascular hypothesis, however, fell into disfavor during 
the late 1970's and early 1980's with the advent of renewed 
enthusiasm for the neural theory of migraine pathophysiology. 
Only the work of John Sterling Meyer, Professor of Neurology at 
Baylor, stands out in support of the vascular hypothesis during 
the 1980's. Meyer studied 324 patients with vascular headache 
using Xenon-133 inhalation methods. This prospective trial 
examinined patients during the course of a non-induced migraine 
attack. Meyer found that 74% of "classic” migraines and 67% of 
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"common" migraines were associated with significant hyperemia 
during the headache phase of the attack. Meyer contends that 
this proof of increased cerebral blood flow supports the vascular 
etiology of migraine headaches.(8) 
The neural hypothesis, as first stated by Liveing in 1873 
(25), proposed that a primary alteration in cerebral function 
caused the migraine headache, and vascular change was only a 
secondary accompaniment. This theory regained popularity when 
researchers noted puzzling disparities between areas of altered 
cerebral blood flow and distribution of migraine symptomatology. 
The headache phase of migraines is often unilateral, yet the 
observed vascular dilatation occurs bilaterally. The 
vasoconstrictive phase, on the other hand, often spreads 
anteriorly from the occipital lobe, crossing arterial anatomical 
boundaries, but not the midline.(24) 
Research upholding the neural theory spans the course of a 
century. From 1890 and the work of Roy and Sherrington (26) to 
Sokoloff's study in 1978 (27), scientists have demonstrated that 
vascular calibre changes as a direct consequence of focal 
metabolic change. Lance et al. in 1983 (28) showed that direct 
neuronal stimulation results in alterations of cerebral 
circulation. Using electrodes, Lance stimulated the locus 
ceruleus in monkeys and noted the onset of intracerebral 
vasoconstriction as well as extracerebral vasodilatation. 
Applying these same techniques to cats, Lance proved that 
trigeminal nerve stimulation caused external carotid artery 
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dilatation.(28) 
The most definitive experiments propounding the neural 
hypothesis come from Jesse Oleson s lab in Denmark during the 
early 1980's. Oleson et al. measured cerebral blood flow using 
Xenon-133 inhalation and photon emission tomography during 
naturally occurring migraine attacks. Differentiating between 
"common" and "classic" migraineurs, Oleson found no alteration in 
cerebral blood flow in twelve patients with "common" migraine 
headache. Three out of eleven "classic" migraine sufferers also 
showed normal perfusion. The remaining eight patients with 
"classic" migraine demonstrated an area of decreased blood flow 
unilaterally. The low-flow regions corresponded to an 
approximate 17% decrease in perfusion and was located on the 
lateral aspect of the side contralateral to the neurologic 
manifestations. At no point was increased perfusion observed, 
and, in fact, the relative oligemia persisted four to six hours 
into the headache phase.(29) 
Prior to these experiments, this same group of researchers 
observed the pattern of hypoperfusion resulting from 
angiographically-induced "classic" migraine. The oligemic region 
progressed anteriorly as a spreading wave at 2mm/minute. The 
area of hypoperfusion did not traverse either the central or 
lateral sulci, and reduced CCb activity and abnormal cortical 
activation were noted throughout the oligemic region.(30,31) 
Oleson and Lauritzen likened this progressive wave of 
hypoperfusion to the so-called Spreading Depression of Leao.(29) 
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Leao originally described the cortical response to noxious 
stimuli in 1944. Following electrode stimulation of the cerebral 
cortex of rabbits, Leao recorded a brief surge in neuronal 
activity which lasted five to ten seconds. This was followed by 
decreased or "depressed" activity which spread outward at a rate 
of 3mm/minute and did not regain normal activity for five to ten 
minutes.(32) Concomitantly, Leao noted a 50 - 100% increase in 
pial artery diameter arising immediately in the wake of the 
spreading wave of depression. This dilatation lasted 1.5 to 3 
minutes and was followed by a longer period of slight 
vasoconstriction.(33) More recent experiments have shown that 
the earliest ionic disturbance associated with spreading 
depression is an increase in extracellular PC .(34) This has led 
some to hypothesize that a hypoxic event might result in 
increased extracellular K+ levels triggering a wave of spreading 
depression.(8) 
Moskowitz (35) expanded upon the similarities between the 
hypoperfusion pattern of migraine and the Spreading Depression of 
Leao by examining the role of Substance P. Substance P, a 
peptide located in primary sensory neurons, affects vascular 
calibre and permeability. Using radioimmunoassay, Moskowitz 
examined multiple laboratory animal species and discovered high 
levels of Substance P in pial arteries, the same vessels that 
Leao noted dilated following the wave of depressed neuronal 
activity. By directly applying Substance P onto cerebral 
vessels, Moskowitz found resultant vasodilatation. Substance P 
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also has other actions such as mast cell degranulation and 
disruption of the blood-aqueous barrier in the eye.(35) Although 
the connection between migraine pathophysiology, the Spreading 
Depresssion of Leao and Substance P remains largely 
controversial, the concept that the observed oligemia associated 
with migraine is secondary to a disruption in the cerebral neural 
elements continues to be central to the neurogenic hypothesis of 
migraine etiology. 
Treatment 
The disagreement surrounding migraine pathophysiology is 
reflected by the disparate treatment modalities advocated. Mild 
migraine headaches often respond to aspirin or a combination of 
aspirin and metoclopramide, a dopamine antagonist which increases 
gastrointestinal motility and effectively raises aspirin 
absorption.(36) More severe episodes require stronger abortive 
therapy. Ergotamine tartrate, a peripheral vasoconstrictor 
acting through alpha adrenergic stimulation, has long been the 
treatment of choice for acute attacks. When taken during the 
prodrome or early after the advent of pain, ergotamine is 
effective in 80 - 90% of migraineurs.(37) Ergotamine use is 
limited by such adverse side effects as nausea, vomiting and 
vasospasm, possibly leading to claudication, gangrene and cardiac 
ischemia.(36,37,38) Drug dependency and increased headache may 
also result after long periods of high dosages. Dopamine, 
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propranolol, erythromycin and troleandomycin all may enhance the 
potentially serious side effects of ergotamine.(36,37) 
Nonsteroidal anti-inflammatory agents, though not yet approved by 
the U.S. Food and Drug Administration, have also been shown to be 
effective in the treatment of migraine. Recent studies have 
shown NSAIDs to have greater efficacy than placebo or 
ergotamine.(39,40) 
Prophylactic medication is recommended for frequency or 
unresponsiveness to abortive therapy. The most widely prescribed 
prophylactic agent is propranolol, a non-specific beta adrenergic 
antagonist. Although the exact pathway of action is unknown, 
postulates include propranolol's inhibition of vasodilatation and 
prevention of cortical arteriolar spasm.(37) 
Those headaches refractory to all other medications may be 
prevented by methysergide. A semi synthetic ergot alkaloid, 
methysergide use is restricted by such deleterious side effects 
as weight gain, peripheral edema, and subendocardial, 
pleuropericardial and retroperitoneal fibrosis.(36) 
Methysergide's prophylactic mechanism is thought to be related to 
its actions as a peripheral antagonist and central agonist of 
serotonin.(37) Tricyclic antidepressants, calcium-channel 
blockers, monoamine oxidase inhibitors, and anti-estrogens all 
have their own proponents.(9,36,41,42,43) The "common" migraine 
subtype "menstrual migraine" even has its own prophylactic drug 
or choice--naproxen, a nonsteroidal anti-inflammatory drug.(44) 
Though efficacy is largely anecdotal, a few well-controlled 
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studies have been performed. 
Table 3. Response to Migraine Prophylaxis 
Agent Patients with >or= 50% Improvement 
Nimodipine 69.0% 
Methysergide maleate 58.3% 
Amitryptyline 55.3% 
Propranolol 51.6% 
Pizotifen 50.9% 
Clonidine hydrochloride 40.9% 
Placebo 34.0% 
Adapted from Gelmers (9) and Couch and Hassanein (41). 
Patients with migraine have been reported to respond to 
placebo in 20 - 40% of cases.(9) Some researchers, therefore, 
have focused on nondrug intervention. Behavioral modification 
techniques including repetition of autogenic phrases, 
electromyographic biofeedback and thermal biofeedback all have 
been utilized with some benefit. When Sargent et al.(45) 
compared these methods to a "no treatment" control group, a 
statistically significant improvement in migraine headaches was 
found. The placebo effect of behavioral modification versus non¬ 
treatment, however, could not be well-controlled. 
The theory behind behavior-related therapy is that migraines 
may occur more frequently during stressful periods or mood 
changes. Levor et al.(46) evaluated 33 migraineurs and concluded 
that although the migraine sufferers were exposed to stress 
levels similar to the general population, they were more likely 
to respond to routine stress with an acute migraine attack. The 
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migraineurs experienced an increase in stressors over a four 
daycourse preceding and including the day of a migraine headache. 
Using self-ratings, Harvey and Hay (47) analyzed mood changes in 
eight migraine patients. This preliminary prospective study 
revealed that migraine patients had reduced depression and an 
increased level of alertness on days immediately prior to 
headache days. 
In addition to stress, multiple external triggers for 
migraine headaches have been cited in the literature, with little 
scientific substantiation. Seasonal and temperature changes as 
well as exposure to flickering lights have been proposed as 
migraine stimuli. Dietary causes such as monosodium glutamate, 
alcohol and foods high in tyramine content are frequently blamed. 
These include such diverse items as chocolate, aged cheese, beer 
and yogurt.(14,15) 
The "Migraine Personality" and Psychopathology 
Clinicians have often noted that persons suffering from 
migraine seem to exhibit a particular constellation of 
personality traits consisting of perfectionism, excessive drive 
and meticulousness. (38) The concept of the "migraine 
personality" implies that migraineurs have a specific combination 
of personality traits on which they can be distinguished from 
persons without migraine.(48) 
Studies investigating the link between migraine and 
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personality have taken two forms. Observational and 
psychoanalytical reports utilize no objective data, but represent 
an aggregate of a specialist's experiences with migraine 
patients. Empirical research uses questionaire and self-report 
inventories. An individual's responses are then correllated with 
specific psychiatric diagnoses. If the latter is community 
rather the clinically based, possible self-selection bias for 
more serious cases or specific socio-economic characteristics 
will be obviated. 
Early observational studies by Wolff (49) and Alvarez (50) 
noted that migraineurs were perfectionists. Touraine and Draper 
(51) and Furmanski (52) stressed anxious qualities. Migraine 
patients were described as defensive by Mitchell and Mitchell 
(53) and as repressing hostilities by Kolb (54) and Friedman and 
Merrit (55). Sacks (56), however, found no composite personality 
common to migraineurs. The applicability of these reports is 
limited by their differing definitions of migraine, lack of 
control groups, and absence of quantitative analysis.(14) 
Empiric research, though, noted many of the same 
characteristics. Utilizing self-administered questionaires, 
Bille (57) concluded that children with migraine were more likely 
to be anxious and tense, and Bildhorff et al.(58) stated that 
adult migraineurs were more inhibited and compulsive. Maxwell 
(59) ascertained that clinic patients with migraine were more 
neurotic according to the Maudsley personality inventory than 
patients without migraine. Using the Jackson Personality 
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Inventory, however, Schmidt et al. (48) found no evidence 
supporting the above traits, but did find that migraine sufferers 
scored lower on scales measuring complexity, risk taking and 
social participation. Others, such as Lucas (21), Davis et 
al.(60), and Henryk-Gutt and Rees (61) identified no reproducible 
"migraine personality." 
The most consistently cited association with a specific 
psychiatric disorder is the link between migraine and depression. 
Studies elucidating this association have focused primarily on 
migraineurs (15,62,63), patients with depression (64,65,66), or 
random community samples (67,68). Although most substantiate the 
correlation between migraine and either depression or anxiety, 
they differ widely in magnitude, sex disparities and individual 
symptom patterns noted. Once again, the inconsistencies may be 
attributed to different definitions and measurement of migraine 
and psychopathology as well as sample bias. 
Co-occurrence of two disorders is further evidenced by 
efficacy of one drug class in treating both diseases and family 
psychiatric evaluations to explore genetic transmission. As 
previously stated, tricyclic antidepressants and monoamine 
oxidase inhibitors have proved beneficial for some migraine 
patients. Well-controlled studies, however, are scarce. 
Familial transmission of both migraine and depression was 
recently investigated by Merikangas et al.(69) They evaluated a 
group of 133 patients with major depression, a group of 82 normal 
controls and 400 interviewed first-degree relatives of the 
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probands and controls. After controlling for the effects of age 
and sex, patients with depression had a significantly greater 
prevalence of migraine than those without depression (relative 
risk = 2.4). Although both migraine and depression were 
familially transmissible, their association was not demonstrated 
to be genetically influenced. Merikangas et al. therefore 
proposed that depression could either be a sequela of migraine or 
the diathesis resulting in both. 
"Menstrual Migraine" 
The postulated relationship between migraine and depression 
raises the question of a possible link between "menstrual 
migraine" and the premenstrual syndrome. Some researchers 
associate the proportionally increased rate of migraine in 
pubertal and post-pubertal females with a specific subset of 
migraine dubbed "menstrual migraine." Approximately 60% of 
female migraineurs correlate migraines with their menstrual 
cycle, usually immediately preceding or during menses.(17) The 
strict definition of "menstrual migraine," however, is that of 
"common" migraines coinciding with the week preceding or the week 
of menstruation. The woman with true "menstrual migraine" will 
never have migraines outside of the paramenstrual period. Digre 
and Damasio (44) applied this rigid definition to a group of 
migraineurs and concluded that 8% of women with migraine have 
"menstrual migraine." Trends within the group of women with 

23 
"menstrual migraine" include migraine onset with menarche, a 
tendency toward remission with menopause, and decreased frequency 
during pregnancy.(17) Between 60% and 80% of women evidence 
gestational improvement, especially during the second and third 
trimesters.(3,17) Estrogen levels rise with pregnancy and fall 
with menopause, but during both, the cyclic change in estrogen 
associated with menstruation is absent. This observation 
triggered the hormonal hypothesis that the relative cyclic change 
in estrogen levels, and not the absolute value, may be a migraine 
stimulus.(17) (see Figure 1) 
Figure 1. Cyclical Changes in Estradiol and Progesterone (70) 
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Welch et al. (71) demonstrated that estrogen increases 
vascular adrenergic receptor production, decreases norepinephrine 
reuptake and inhibits norepinephrine degradation. Welch 
hypothesized that under normal conditions, these changes balance 
each other for no net effect. With the cyclical drop in 
estrogen, though, the second two actions decrease, and the 
unopposed extra adrenergic receptors cause severe 
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vasoconstriction. Compensating homeostatic mechanisms reacting 
to ischemia lead to vasodilatation and "menstrual migraine." 
Another factor implicating hormone levels in migraine 
etiology is the correlation between oral contraception and 
increased migraine frequency. Some women date the onset of their 
migraines to several months following starting birth control 
pills. Furthermore, in those women who have migraines while 
using oral contraceptives, almost 70% note decreased frequency of 
migraines with cessation of the pill.(17) The premenstrual fall 
in estrogren is even greater with estrogen-containing oral 
contraceptives than in the normal cycle, additionally supporting 
the hypothesis that "menstrual migraines" are triggered by 
relative changes in estrogen level.(71) These trends of 
"menstrual" or "hormonally-induced" migraine remain contested in 
the literature, though, and certainly do not hold true for all 
female migraineurs. A follow-up study by Whitty and Hockaday of 
40 female patients with migraine evidenced no overall decrease in 
migraine frequency with menopause. Approximately equal numbers 
of women reported an increase in migraines as those who noted 
decreased or unchanged frequency.(72) 
Late Luteal Phase Dysphoric Disorder 
Late Luteal Phase Dysphoric Disorder (LLPDD), often 
previously termed Premenstrual Syndrome, is a proposed diagnosis 
listed in DSM IIIR. (73) The diagnosis encompasses a range of 
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emotional and behavioral disturbances associated with the last 
week of the luteal phase of the menstrual cycle. For most women, 
this period coincides with the week prior to menses, and lasts no 
longer than a few days following the advent of menses. This is 
the same time period as that of "menstrual migraine." Late 
Luteal Phase Dysphoric Disorder is applicable only to the woman 
suffering social or occupational impairment with most of her 
cycles during the course of a year. The symptoms must also remit 
within a few days of the start of the follicular phase, thereby 
excluding late luteal phase worsening of existing psychopathology 
such as Major Depression or Panic Disorder. Because of 
discrepancies involving retrospective diagnosis, daily self- 
ratings throughout two symptomatic cycles are necessary prior to 
assigning the diagnosis. 
Figure 2. Diagnostic Criteria for LLPDD (73) 
A. Symptoms listed in section B occurred during the last week of 
the luteal phase and ended within a few days of the start of 
the follicular phase of the menstrual cycle. 
B. At least one of either (1), (2), (3), or (4), and at least 
five total of the following: 
(1) marked affective lability 
(2) persistent anger or irritability 
(3) anxiety or tension 
(4) depressed mood, hopelessness or self-deprecation 
(5) decreased interest in usual activities 
(6) lack of energy 
(7) difficulty in concentrating 
(8) change in appetite 
(9) change in sleep patterns 
(10) physical symptoms such as breast tenderness or swelling, 
headaches, sensation of "bloating," or weight gain. 
C. These changes interfere with work or usual activities and 
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interpersonal relations. 
D. This is not merely an acceleration of an underlying disorder 
such as Major Depression, Panic Disorder, Dysthymia, or a 
Personality Disorder. 
E. Confirmation by prospective daily self-ratings during at 
least two symptomatic cycles. 
Frank first described premenstrual changes in 1931 (74). He 
noted tension, seizures, asthma, cyclic edema and subcutaneous 
hemorrhages in fifteen women 7-10 days prior to menses. Frank 
ascribed these symptoms to "excess circulating levels of female 
sex hormone."(74) Although much research has followed his 
original observations, most etiological hypotheses remain based 
upon the concept of altered gonadal steroid levels. Proposed 
disturbances include decreased estrogen levels due to reduced 
renal and hepatic clearance or increased production, and changes 
in the ratio of estrogen to progesterone secondary to 
progesterone deficiency (75). Scientific research, however, has 
not clarified the controversy. Of ten studies reviewed by 
Rubinow and Roy-Byrne (75), five reported decreased progesterone 
during the late luteal phase, one revealed increased progesterone 
early in the luteal phase, and three found normal progesterone 
levels. Similar disparities abound in studies of estrogen levels 
in those with premenstrual syndrome. All of this research, 
however, measures peripheral hormone levels, which may or may not 
correspond to fluctuations in the central nervous system. In a 
review of endocrine theories of PMS, Strickler (76) concluded 
that some interaction between hormones and neurotransmitters such 
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as endogenous opiate peptides or catecholamines was the most 
likely cause for PMS. To support his hypothesis, Strickler cited 
the covarience of plasma estrogen and endorphin. He also noted 
that many of the symptoms of PMS such as anxiety and agitation 
are associated with raised endorphin levels. Therefore, not only 
do the time courses of "menstrual migraine" and LLPDD overlap, 
but their postulated etiologies are based on similar mechanisms 
of cyclical endocrine change and neurotransmitter disturbance. 
Proposal 
Studies examining the association between depression and 
premenstrual syndrome have been limited either by small sample 
size, lack of control group, or retrospective diagnosis of 
PMS.(77) Although flawed by study design, each did report 
increased occurrence of depression with PMS. One of the 
diagnostic criterion for Late Luteal Phase Dysphoric Disorder is 
headache, although not specifically migraine.(73) Can these 
associations between headache and LLPDD and LLPDD and depression 
account for the relationship between migraine and depression? If 
so, differing rates of depression may be observed in "menstrual 
migraine" compared with other forms of migraine. Also, the type 
of depression may be disimilar. Halbreich(78) states that women 
with LLPDD more frequently experience atypical depression, 
anxious-agitated depression and hostile depression. 
This study investigates the association between migraine 
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headaches and psychopathology in a sample of men and women in 
treatment for migraine. Within the group of migraineurs, 
patients will be subdivided by sex and type of migraine-- 
"classic" or "common." The subgroup of women with "menstrual 
migraine" will also be individually analyzed and compared for 
increased rates of depression or specific subtypes of depression. 
Therefore, if the rate of depression is greater in patients with 
"menstrual migraine," not only may we infer that the endocrine 
system underlies the association noted between migraine and 
depression, but also that "menstrual migraine" is a separate 
entity from other forms of migraine. 
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MATERIALS AND METHODS 
The subjects consisted of men and women previously 
diagnosed as having migraine headaches, and currently in 
treatment with a neuropsychiatrist. All patients were approached 
first by their physician, and the study and its voluntary nature 
was explained to them. If the patient agreed, he or she was then 
contacted by a researcher trained in psychological assessment and 
interviewing. The interview session lasted from 1-3 hours and 
consisted of a demographic data and medical history 
questionnaire, a migraine symptom review (see Appendix A) and the 
Schedule for Affective Disorders and Schizophrenia (SADS-L), for 
psychiatric status and diagnosis. The migraine symptom review 
investigates not only the specific characteristics of the 
migraine, but also migraine triggers, treatment, associated 
medical illnesses and family history. Subtype classification of 
"classic" is assigned if the patient describes a well-defined 
aura preceding a unilateral headache. All other subjects are 
"common" migraineurs. "Menstrual migraine" is independently 
designated if a female patient experiences increased headache 
frequency or severity either before or during menses. 
The SADS-L is a "lifetime" structured interview which 
records information concerning past and current episodes of 
illness. Information on signs and symptoms are collected 
systematically and diagnosis is based on established criteria for 
25 adult psychiatric disorders.(79,80,81) The six categories we 
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utilized are major depression, bipolar disorder, panic disorder, 
generalized anxiety, obsessive/compulsive disorder and phobic 
disorder. The research disgnostic criteria for each is presented 
in Appendix B. Statistical significance for this study was 
determined by using chi-square analysis for categorical responses 
and t-test evaluations for those questions with a range of 
possible responses. 
Additionally, each proband received a self-assessment 
package to return at his or her convenience. This report package 
contained the Maudsley Personality Inventory (MPI, Eysenck), the 
Dimensions of Temperament Scale (DOTS, Lerner), the Social 
Adjustment Scale - Self-Report (SAS-SR, Weissman) and the Symptom 
Checklist 90 (SCL-90, Derogatis). During that same interview, a 
family pedigree was obtained and Family History Questionnaires 
were reviewed for each first-degree family member (i.e. parents, 
siblings and children). Although all of these indices were not 
utilized for this investigation, they remain available for future 
analyses. 
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RESULTS 
The migraineurs interviewed consisted of 11 (15%) males and 
60 (85%) females. They range in age from 16 to 73, with a mean 
age of 39. Demographic data reveals a racial distribution of 99% 
white and 1% black. The mean level of education for the group is 
college, with the least educated a junior high school graduate, 
and the most educated holding a graduate or professional degree. 
61% are married, 15% divorced, 1% widowed and 23% have never 
married. Demographic data is summarized in Table 4. 
Migraine sub-types were classified by the following 
procedure: if the patient described a definite migraine 
prodrome, and the headache was always unilateral and never 
bilateral, then the proband was assigned to the "classic" 
migraine group. All others were called "common" migraineurs. 
The determination of "menstrual" migraine was independent of 
the "classic" versus "common" division. Women with "menstrual" 
migraine were those who responded positively to the question, 
"Does menstruation seem to trigger your headache?" Only those 
who specified either "pre" menstruation or "during" menstruation 
were counted as positive answers. 
According to these standards, the interview group consisted 
of 27 (38%) "classic" and 44 (62%) "common" migraineurs. The 
average age of onset for all subjects was 16.8 years, with a 
range of 2-45 years (see Figure 3 for distribution). The 
average migraine was described as causing moderate impairment and 
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lasting 23 hours. 73% had a family history of headache, and 76% 
also suffered from tension headaches. The female migraineurs 
were asked specific questions regarding worsening headache and 
the menstrual cycle. These data are summarized in Table 5. 
The mean age of onset of migraine in "classic" and 
"common" migraine patients was 16.7 and 16.9, respectively, and 
is compared by t-test in Table 6. The migraine severity for both 
groups is summarized using a t-test in Table 7. The association 
of tension headaches with "common" versus "classic" migraine is 
explored in Table 8. Another possible disparity between 
"classic" and "common" migraineurs was tested in Table 9 by 
examining the presence of family history of migraine. Migraine 
severity, association with tension headache and family migraine 
history did not vary by "classic"-"common” subtype. 
Dividing these same probands by the criteria for "menstrual 
migraine," 37 (53.5%) of the study group were classified as 
having "menstrual migraine.” Two patients could not be assigned 
because of insufficient information. The same var.iables--age of 
migraine onset, severity, tension headaches and family history-- 
were applied to the "menstrual migraine" sub-group in Tables 10, 
11, 12 and 13, respectively. Although age of onset and tension 
headache were not dependent on "menstrual migraine" 
classification, "menstrual migraineurs" tended to have decreased 
migraine severity and increased migraine family history, p^O.076 
and p=0.070, respectively. 
A synopsis of the psychopathology within the proband group 
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is displayed in Table 14. This data is analyzed for association 
with migraine sub-types "common," "classic" and "menstrual 
migraine" using the chi-square method in Tables 14 and 16. Table 
17 shows the results for "menstrual migraine" when comparing only 
the female migraineurs and Table 18 investigates possible sex 
disparities in psychopathology. Lifetime prevalence on 
psychopathology did not vary by sex or "menstrual migraine" 
classification. Patients with "classic" migraine, however, did 
tend to have increased rates of panic disorders (p=0.10). 
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Table 4. 
Figure 3 
# of 
Probands 
Demographic Data 
Age 
Sex 
Race 
Education 
Marital Status 
Mean 39 years Range 16-73 years 
15% males 85% females 
99% white 1% black 
68% college level 
61% married 
Distribution of Age of Migraine Onset 
18- 
16- 
14- 
12- 
10- 
8- 
6- 
4- 
2- 
11 
15 
16- 
20 
0- 
5 
6- 
10 
Age of Onset (years) 

Table 5. Migraine and the Menstrual Cycle 
Proportion of subjects with precipitation 
or worsening of headaches by: 
Menstruation 64% 
Pregnancy 30% 
Childbirth 5% 
Post-partum 14% 
Menopause 16% 
Table 6. "Classic" vs. "Common" Migraine Onset - t-test 
DF Sig 
Classic 
Mean Std 
N Age Dev Range 
27 16.7 9.3 5-39 
41 16.9 10.4 2-45 
0.055 66 N.S 
Common 
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Table 7. "Classic" vs. "Common" Migraine Severity - t-test 
Std 
N Mean Dev Range T DF Sig 
Classic 27 4.4 1.3 2-6 
0.870 69 N. S. 
Common 44 4.1 1.7 1-6 
Numerical Correlation of Severity 
1. only mild subjective distress, no impairment 
2. considerable distress, but no apparent impairment in function 
3. mild impairment, primarily in daily activities at home 
4. moderate impairment, extending to social and work activities 
5. severe 
6. extreme, essentially incapacitated and must go to bed 
Table 8. Subjects with Tension Headache by Classic-Common 
Subtype 
Tension Headache 
Yes X2 DF Sig 
Classic 
Common 
18 (66.7%) 
2.109 1 N.S. 
36 (81.8%) 

37 
Table 9. Family History of Migraine by Classic-Common Subtype 
Family Headache History 
Yes X2 DF Sig 
Classic 
Common 
19 (70.4%) 
0.137 1 N.S. 
32 (74.4%) 
Table 10. "Menstrual Migraine" Age of Onset - t-test 
Menstrual 
Migraine N 
Mean 
Age 
Std 
Dev Range T DF Sig 
Yes 36 18.4 9.7 4-45 CO
 
1—1
 
1
 65 N.S 
No 31 14.8 10.0 2-40 
Table 11. "Menstrual Migraine" Severity - t-test 
Menstrual 
Migraine N Mean 
Std 
Dev Range T DF Sig 
Yes 37 3.97 1.5 1-6 
1.80 67 0.076 
No 32 4.63 1.5 1-6 
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Table 12. "Menstrual Migraine" and Tension Headache 
Menstrual 
Migraine 
Tension Headache 
Table 13. "Menstrual Migraine" and Family History 
Family History of Headache 
Yes X2 DF Sig 
Menstrual Yes 
Migraine 
No 
30 (81.1%) 
3.281 1 0.070 
19 (61.3%) 
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Table 14. Lifetime Prevalence of Psychopathology in Probands and 
Age of First Episode 
Diagnosis 
Proband 
(%) 
Mean Age of 
First Episode (years) 
Major Depression 59.2% 27.0 
Bipolar Disorder 4-2% 31.0 
Panic Disorder 19.7% 24.9 
Generalized Anxiety 40.8% 22.1 
Obsessive/Compulsive 8.5% 19.5 
Phobic Disorder 32.4% 15.3 
Table 15. "Classic" vs. "Common" Migraine and Psychopathology 
Diagnosis 
"Classic" 
N=2 7 
"Common" 
N=44 X2 Prob 
Major Depression 70.4% 52.3% 2.268 0.132 
Bipolar Disorder 7-4 % 2.3% 1.090 0.296 
Panic Disorder 29.6% 13.6% 2.704 0.100 
Generalized Anxiety 40.7% 40.9% 0.000 0.989 
Obsessive/Compulsive 11-1% 6.8% 0.399 0.528 
Phobic Disorder 37.0% 29.6% 0.429 0.513 
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Table 16. "Menstrual Migraine" and Psychopathology 
Menstrual Migraine 
Diagnosis 
Yes 
N=3 7 
No 
N=32 X2 Prob 
Major Depression 62.2% 59.4% 0.056 0.813 
Bipolar Disorder 5-4% 3-1% 0.215 0.643 
Panic Disorder 21-6% 18.8% 0.087 0.767 
Generalized Anxiety 43.2% 37.5% 0.235 0.628 
Obsessive/Compulsive 8-1% 9.4% 0.035 0.852 
Phobic Disorder 37.8% 28.1% 0.728 0.393 
Table 17. "Menstrual Migraine" and Psychopathology--Females Only 
Menstrual Migraine 
Diagnosis 
Yes 
N=37 
No 
N=21 X2 Prob 
Major Depression 62.2% 52.4% 0.528 0.467 
Bipolar Disorder 5.4% 4.8% 0.915 0.915 
Panic Disorder 21.6% 19.1% 0.054 0.816 
Generalized Anxiety 43.2% 28.6% 1.225 0.268 
Obsessive/Compulsive 8-1% 4.8% 0.234 0.629 
Phobic Disorder 37.8 % 23.8% 1. 197 0.274 
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Table 18. Sex and Psychopathology 
Diagnosis 
Male 
N=ll 
Female 
N=60 X2 Prob 
Major Depression 72.7% 56.7% 0.992 0.319 
Bipolar Disorder 0.0% 5.0% 0.574 0.449 
Panic Disorder 18.2% 20.0% 0.019 0.889 
Generalized Anxiety 54.6% 38.3% 1. Oil 0.315 
Obsessive/Compulsive 18.2% 6-7% 1.593 0.207 
Phobic Disorder 36.4% 31.7% 0.094 0.760 
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DISCUSSION 
Psychiatric disorders within the migraine population did not 
vary by "common"-"classic" subtype or "menstrual migraine." 
Patients with "menstrual migraine," however, tended to have less 
severe headaches and a greater family history of migraine. 
The subject population was mainly middle aged, white, highly 
educated and married. This may reflect the referral source, a 
medical specialist in private practice. Epidemiologic studies, 
however, have demonstrated that no correlation exists between 
socioeconomic status and migraine.(18,19) 
The preponderance of females in the sample (5.5 : 1, 
female:male) exceeds the ratio usually reported of 1.5 - 2 : 
1.(14) Our probands, though, are a treated sample and would not 
be expected to correspond to ratios found through random 
community surveys. 
Therefore, we hope to obviate the bias of a treated sample 
by comparing prevalence of psychopathology between subdivisions 
of the entire group. Any comparison to community controls would 
not be valid because patients under the care of a 
neuropsychiatrist should have higher rates of psychiatric 
disorders because of a treatment-seeking bias. Within the 
sample, all of the patients have had the same self-selection. 
In their epidemiologic review of affective disorders, 
Weissman et al. (82) reported studies showing community lifetime 
prevalence of nonbipolar depression which ranged from 6 - 18%. 
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However, Merikangas et al. (69) found a lifetime prevalence of 
major depression of 35% in community subjects with migraine. The 
lifetime prevalence of major depression in our treated population 
is 59.2%. which is approximately double that of the community 
migraine sample. Furthermore, subjects with anxiety disorders 
with migraine exhibited a lifetime prevalence rate of 77% as 
compared to a rate of 53% in non-migraine sufferers. Therefore, 
although the rate of psychiatric disorders within our study is 
high compared to random community trials, the disparity is less 
significant with respect to the general population of 
migraineurs or migraine patients in treatment for anxiety 
disorders. 
The migraine characteristics for the interview group follow 
the trends reported in the literature. The average migraine 
onset was 16.8 years, which is older than that listed by Linet 
and Stewart (14), but younger that that found by Merikangas, et 
al. (69) Greater than 50% of the probands experienced their 
first migraine between the ages of 5 and 17. 
Family history of migraine was positive in 73% of our 
patients. In their review of migraine, Linet and Stewart (14) 
cited studies showing 10 - 90 % of migraineurs with a positive 
family history of migraine. The varied definitions of migraine 
may account for this discrepancy. In our survey, we required 
only the presence of a recurrent incapacitating headache, and not 
a formal diagnosis of migraine. 
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"Common" vs. "Classic" 
38% of the study group was classified as having "classic" 
migraine and 62% as having "common" migraine. Although this is 
higher than the community-derived figure of 10 - 15% "classic," 
(7,8) we did utilize a very strict definition to divide the 
migraineurs. Only those patients with purely unilateral headache 
and a well-defined prodrome were assigned to the "classic" group. 
We did, however, classify patients according to the description 
of their symptoms. This may not always reflect the actual 
characteristics of the headache nor their change over time. 
Additionally, migraine sufferers often experience a mixture of 
"classic" and "common" migraines, with one predominating during a 
specific time period. 
Comparing the "classic" and "common" migraineurs, there were 
no statistically significant differences in age of onset, family 
history or associated tension headaches. "Common" migraineurs 
reported tension headaches more than "classic" migraineurs, 81.8% 
as opposed to 66.7%, but the chi-square probability was 0.146. 
There was also no significant disparity in the rate of 
psychiatric disease between the two subgroups, although the 
"classic" migraineurs evidenced higher rates in all diagnostic 
categories except generalized anxiety. However, there was a 
trend toward association between "classic" migraine and panic 
disorder. 
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"Menstrual Migraine" 
Whereas "classic" migraine was rigidly defined, "menstrual 
migraine" was not. 64% of the females linked precipitation or 
increased severity of migraine to the time either before or 
during menses. These women were then considered "menstrual 
migraineurs." This value far exceeds that reported by Digre and 
Damasio (44) of 8%. However, they included women who solely 
suffered from migraines during the paramenstrua1 period and were 
headache-free the remainder of the month, whereas those subjects 
from the present study were unselected for this condition. The 
other questions regarding migraine and the menstrual cycle 
elicited expected results. 30% of the women who had been 
pregnant experienced more migraines during pregnancy. This 
observation is consistent with the findings of research 
demonstrating first trimester worsening and second and third 
trimester improvement of migraine (3,17). 14% of the women in 
our sample cited post-partum migraine increase, which may imply 
that their migraines had decreased during the latter part of 
pregnancy. 16% of the women had worse migraines following 
menopause, a figure supporting Whitty and Hockaday's claim than 
migraine frequency does not necessarily decrease with 
menopause.(72) 
Analyzing the "menstrual migraine" data, those with 
"menstrual migraine" showed a trend toward less severe migraine 
(p=0.076). They also had later migraine onset (18.4 years 
compared to 14.8 years), although not of statistical 
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significance. Increased age reflects onset at or following 
puberty, and not during childhood. "Menstrual migraineurs" 
demonstrated an increased rate of familial migraine (p=0.070), 
but no difference in associated tension headache. The trends 
toward less severity and higher rates of familial migraine may 
signal that "menstrual migraine" is a separate form of headache 
from the rest of migraine. If these disparities remained 
significant with a larger sample size, laboratory study to 
evaluate differing hormonal pathophysiology would be warranted. 
There was no correlation, however, between "menstrual 
migraine" and psychopathology. The data were analyzed first 
comparing "menstrual migraineurs" with all other probands and 
then with females, only. There was no real difference between 
these two methods of comparison, though, because the sex of the 
patients was not related to the rate of psychopathology. 
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CONCLUSION 
Although there is an enxtremely high frequency of lifetime 
psychiatric disorders among subjects with migraine, we have 
demonstrated no association between migraine subtypes and 
psychopathology. "Classic," "common" and "menstrual migraine" 
each showed increased rates of psychiatric disease compared to 
random community samples, but there was no significant disparity 
between the groups. These results imply that the hormonal 
changes during the menstrual cycle postulated to worsen both 
"menstrual migraine" and LLPDD are not responsible for the 
increased rates of psychopathology observed in migraine 
patients. 
This is not, however, the ideal study to assess the inter¬ 
relationship between migraine, LLPDD and psychopathology. Both 
"menstrual migraine" and LLPDD should be diagnosed prospectively, 
rather than retrospectively. Retrospective diagnosis may 
artificially increase the prevalence of each. Patients often 
correlate headaches or mood changes with menses, but careful 
daily self-ratings fail to verify this association. Therefore, 
any research involving "menstrual migraine" and LLPDD should 
begin with daily self-assessment throughout two symptomatic 
cycles. The proband should note the presence or absence of 
headache daily. If any migraines occur outside of the 
paramenstrual time period, the week preceding and week during 
menses, the patient would fail to have "menstrual migraine" by 
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the strictest of definitions. Similarly, the patient would 
assess daily mood alterations. Because of subtle changes and the 
variability of patient reporting, a standardized instrument such 
as that developed by Keye (83) would be appropriate. Following 
ascertainment that the proband has both "menstrual migraine" and 
LLPDD, psychological assessment begins with the SADS-L. 
Additional diagnostic indices may be utilized, including the MPI, 
DOTS, SAS-SR and SCL-90 or any other recognized psychiatric 
instrument. These results should be compared with multiple 
control groups to correct biases inherent in the study. Possible 
controls include "common" or "classic" migraineurs, female 
migraineurs, females with tension headaches and females with 
chronic pain. The last of these would evaluate pain as the cause 
of psychopathology, and the first three would elucidate the 
effects of sex and type of headache. Frequent blood samples from 
all groups coudl be obtained to verify that the probands 
experience cyclical estrogen and progesterone levels. None of 
these patients should currently be pregnant, use birth control 
pills or have undergone menopause. 
In order to highlight how changes from the normal cycle of 
hormones affect migraine, a few of the Migraine Symptom Review 
questions should be reworded. Currently, the questionnaire asks 
if the proband's migraines worsened with birth control pill use, 
pregancy, childbirth, post-partum, and menopause. Actually, this 
query should have been phrased, "Do your headaches get better or 
worse...", since many studies suggest that women experience fewer 
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migraines during pregnancy and after menopause. Also, the 
question concerning birth control pills would be more useful if 
divided into two parts--"Have you ever taken birth control 
pills?" and, if so, "Were your headaches better or worse while 
you used BCPs?" This would avoid the confusion of a negative 
response for both patients who had never taken BCPs and for those 
whose migraines were not more severe or frequent with BCP use. 
This thesis was designed as a pilot study to test further 
the relation between migraine and psychiatric disorders and our 
methods for assessing this association. Through analyzing the 
results of these first 71 interviews, we have discovered ways to 
make the Migraine Symptom Review a more reliable diagnostic 
instrument. The Migraine Symptom Review, in its current form, 
provides useful information regarding "classic" and "common" 
classification, migraine symptoms, triggers and treatment 
efficacy. The "menstrual migraine" section, however, could be 
improved by a prospective disgnostic scheme and rewording of 
questions concerning change in migraine with lifetime alterations 
in the menstrual cycle, as noted above. These revisions, in 
conjuction with analysis of the personality inventories and 
family history questionnaires already obtained, should yield an 
in-depth profile of the migraineur, subtype of migraine, 
psychopathology and the familial transmission of each. 
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1. Have you ever suffered from headaches? 
2. At what age did you have your first headache? 
3. How often do you have your headaches? 
Daily? 
Weekly? 
Monthly? 
Bi-Monthly? 
Annually? 
Less than annually? 
4. Do you tend to get migraines during a specific season? 
Winter? 
Spring? 
Summer? 
Fall? 
5. Do your migraines seem to occur during a particular month? 
6. Is the particular time of day related to your migraines? 
Morning? 
Afternoon? 
Evening? 
7. Have you taken any medication to prevent your migraines? 
Beta-blockers? 
Tricyclic antidepressants? 
Mono Amine Oxidase Inhibitors? 
Lithium? 
Methysergide? 
Calcium-channel blockers? 
8. Do you take any medication to treat an acute migraine? 
Narcotics? 
Anti-inflammatories? 
Analgesics? 
Ergotamine? 
Oxygen? 
9. What is the most helpful treatment for an acute attack? 
10. How long do your migraines usually last 
11. Do you have a pre-headache warning? 
Does it consist of: 
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Visual symptoms? 
Nausea? 
Weakness? 
Numbness? 
Dizziness? 
12. Is the onset of discomfort gradual? 
13. When you have a headache, have you also 
a) lost your appetite for food? 
experienced nausea? 
vomiting? 
diarrhea? 
b) been unable to expose your eyes to light? 
c) had visual difficulties such as 
blurring? 
teichopsia (showers o f light)? 
hemianopia (blindness in 1/2 of visual field)? 
scotoma (blind spot)? 
14. Do you have a family history of migraine? 
15. Would you characterize the pain you experience as 
Throbbing? 
Steady? 
Unilateral? 
Bilateral? 
Extending to neck muscles? 
Stabbing? 
Bursting? 
Squeezing? 
Causing scalp tenderness? 
Ice pick pain? 
16. Would you describe the majority of you migraines as 
Only mild subjective distress, no impairment? 
Considerable distress, but no apparent impairment? 
Mild impairment, primarily in daily activities at home? 
Moderate impairment, extending to social and work activities? 
Severe? 
Extreme, essentially incapacitated and must go to bed? 
17. Does any particular situation seem to trigger your headache? 
While relaxing? 
Does it waken you from sleep? 
Does sleep relieve it? 
Does it get worse during sleep? 
Sleeplessness? 
Depression? 
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Anxiety? 
Injury? 
Illness? 
A life crisis such as marriage, divorce or death? 
Stress? 
After periods of prolonged stress? 
After eating particular foods? 
Chocolate? 
Chinese food (MSG)? 
Hot dogs (nitrate)? 
High tyramine foods such as cheese, yogurt, sour cream, 
chicken liver, fresh baked breads, sausages, nuts, pork, 
beans, herring, vinegar? 
Artificial sweeteners? 
Coffee? 
Tea? 
Other caffeine-containing beverage? 
Diet soft drinks? 
After drinking alcohol? 
Beer? 
Wine? 
Other alcoholic beverages? 
Drug usage? 
Smoking? 
Weather change? either temperature or humidity 
If female: 
Menstruation? pre, during or post 
Oral contraceptive use? 
Pregnancy? 
Childbirth? 
Post-partum? 
Menopause? 
Have you had a hysterectomy? 
18. Do you have any of the following medical problems? 
Heart disease? 
Palpitations? 
Mitral valve prolapse? 
Epilepsy? 
Hypertension? 
Cerebrovascular disease or stroke? 
Asthma? 
Hay fever? 
Vertigo or dizziness? 
Gastroesophageal reflux or hiatal hernia? 
Peptic ulcer disease? 
Nephrolithiasis? 
Arthritis? 
Diabetes? 
Hypoglycemia? 
Hypothyroidism? 
Hyperthyroidism? 
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Tension headaches? 
Urinary tract infections? 
Raynauds disease (hands or feet turn red, blue or white in 
response to cold)? 
Excercise intolerance? 
Skin disease (acne, psoriasis)? 
Easy bruising? 
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Appendix B 
SADS-L Criteria for Psychiatric Diagnosis (79,80,81) 
Major Depression 
A through F are required for the episode of illness being 
considered. 
A. One or more distinct periods with dysphoric mood or pervasive 
loss of interest or pleasure. The disturbance is characterized 
by symptoms such as the following: depressed, sad, blue, 
hopeless, low, down in the dumps, "don't care anymore," or 
irritable. The disturbance must be prominant and relatively 
persistent but not necessarily the most dominant symptom. It 
does not include momentary shifts from one dysphoric mood to 
another dysphoric mood, e.g., anxiety to depression to anger, 
such as are seen in states of acute psychotic turmoil. 
B. At least five of the following symptoms are required to have 
appeared as part of the episode for definite and four for 
probable (for past episodes, because of memory difficulty, one 
less symptom is required). 
(1) Poor appetite or weight loss or increased appetite or 
weight gain (change of 1 lb. a week over several weeks 
or 10 lbs. a year when not dieting). 
(2) Sleep difficulty or sleeping too much. 
(3) Loss of energy, fatigability, or tiredness. 
(4) Psychomotor agitation or retardation (but not mere 
subjective feeling of restlessness or being slowed 
down). 
(5) Loss of interest or pleasure in usual activities, 
including social contact or sex (do not include if 
limited to a period when delusional or hallucinating). 
(The loss may or may not be pervasive.) 
(6) Feelings of self-reproach or excessive or inappropriate 
guilt (either may be delusional). 
(7) Complaints or evidence of diminished ability to think 
or 
concentrate, such as slowed thinking, or indecisiveness 
(do not include if associated with marked formal thought 
disorder). 
(8) Recurrent thoughts of death or suicide, or any suicidal 
behavior. 
C. Duration of dysphoric features at least one week beginning 
with the first noticeable change in the subject's usual condition 
(definite if lasted more than two weeks, probable if one to two 
weeks). 
D. Sought or was referred for help from someone during the 
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dysphoric period, took medication, or had impairment in 
functioning with family, at home, at school, at work, or 
socially. 
E. None of the following which suggest Schizophrenia is present: 
(1) Delusions of being controlled (or influenced), or of 
thought broadcasting, insertion, or withdrawal. 
(2) Non-affective hallucinations of any type throughout the 
day for several days or intermittently throughout a one 
week period. 
(3) Auditory hallucinations in which either a voice keeps up 
a running commentary on the subject's behaviors or 
thoughts as they occur, or two or more voices converse 
with each other. 
(4) At some time during the period of illness had more than 
one month when he exhibited no prominent depressive 
symptoms but had delusions or hallucinations (although 
typical depressive delusions such as delusions of guilt, 
sin, poverty, nihilism, or self-deprecation, or 
hallucinations with similar content are not included). 
(5) Preoccupation with a delusion or hallucination to the 
relative exclusion of other symptoms or concerns (other 
than typical depressive delusions of guilt, sin, 
poverty, nihilism, self-deprecation or hallucinations 
with similar content). 
(6) Definite instances of marked formal thought disorder, 
accompanied by either blunted or inappropriate affect, 
delusions or hallucinations or any type, or grossly 
disorganized behavior. 
F. Does not meet the criteria for Schizophrenia, Residual 
Subtype. 
Manic Disorder 
A through E are required for the episode of illness being 
considered. 
A. One or more distinct periods with a predominantly elevated or 
irritable mood. The elevated or irritable mood must be a 
prominant part of the illness and relatively persistent although 
it may alternate with depressive mood. Do not include if 
apparently due to alcohol or drug intoxication. 
B. If the mood is elevated at least three of the following 
symptom categories must be definitely present to a significant 
degree (four symptoms if mood is only irritable): 
(1) More active than usual--either socially, at work, 
sexually, or physically restless. 
(2) More talkative than usual or felt a pressure to keep on 
talking. 
(3) Flight of ideas or subjective experience that thoughts 
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are racing. 
(4) Inflated self esteem (grandiosity, which may be 
delusional). 
(5) Decreased need for sleep. 
(6) Distractibility, i.e., attention is too easily drawn to 
unimportant or irrelevant external stimuli. 
(7) Involvement in pleasurable activities without 
recognizing the high potential for painful consequences, 
e.g., buying sprees, sexual indiscretions, foolish 
business investments, reckless driving. 
(8) Provocative, obnoxious, arrogant, manipulative behavior, 
causing difficulty for friends, co-workers, family. 
C. Overall disturbance is so severe that at least one of the 
following is present: 
(1) Meaningful conversation is impossible. 
(2) Disruption of role function socially, with family, at 
home, or at work. 
(3) Delusions or hallucinations at peak of excited period. 
D. Manic features lasted more than one week or were terminated 
by EOT or medication. 
E. At least one episode of illness in which none of the 
following were present except transiently during the most excited 
period. 
(1) Bizarre or fantastic delusion(s) (including delusions of 
being controlled or influenced or thought broadcasting) 
having apparently nothing to do with Mania. 
(2) Hallucinations of any type throughout the day for 
several days or intermittently throughout a six month 
period. 
(3) Auditory hallucinations in which two or more voices 
discuss the patient, his thoughts or actions in the 
third person. 
(4) At some time during the period of illness had delusions 
or hallucinations for more than one week in the absence 
of prominent affective (depressed or manic) 
symptomatology. 
(5) At some time during the period of illness had more than 
one week when he exhibited no prominent manic 
symptomatology but had several instances of verbal 
production that made communication difficult because of 
a lack of logical or understandable organization 
(obvious thought disorder). 
Panic Disorder 
A through E are required for the episode of illness being 
considered. 
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A. At least six panic attacks distributed over a six week period 
for a definite diagnosis and three attacks occuring over a three 
week period for a probable diagnosis. They must occur at times 
other than during marked physical exertion or a life-threatening 
situation, and in the absence of a medical illness that could 
account for symptoms of anxiety. (Do not include if lasts most 
of the day or if limited to a circumscribed phobic stimulus.) 
B. The panic attacks are manifested by discrete periods of 
apprehension or fearfulness with at least three of the following 
symptoms present during the majority of attacks required for 
definite and two for probable (for past episodes, because of 
memory difficulty, one less symptom is required). 
(1) dyspnea 
(2) palpitations 
(3) chest pain or discomfort 
(4) choking or smothering sensations 
(5) dizziness, vertigo, or feelings of unreality 
(6) paresthesias (tingling) 
(7) sweating 
(8) faintness 
(9) trembling or shaking 
(10) fear of dying, going crazy, or losing control during an 
attack. 
C. Nervousness between the panic attacks. 
D. The condition has resulted in either impairment in 
functioning with family, at home, at school, at work, or 
socially, seeking or being referred for help from someone, taking 
medication, or abusing alcohol or drugs. 
E. The panic attacks are not limited to an episode of probable 
or definite Major Depression, Schizophrenis, or Schizo-affective 
Disorders, nor are they limited to a period of two months prior 
to, or two months after such an episode. 
Generalized Anxiety 
A through F are required for the episode of illness being 
considered. 
A. An episode of illness in which relatively persistent 
generalized anxious mood dominates the clinical picture. The 
anxious mood may be described as anxious, nervous, jittery, 
tense, restless, or "uptight." 
B. At least one of the following: 
(1) Difficulty falling asleep. 
(2) Sweating, blushing, dizziness, palpitations, or 
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shortness of breath. 
(3) Muscular tension or tremors. 
(4) Persistent worrying about future events. 
(5) Fidgeting or inability to sit still. 
C. Duration of episode at least two weeks beginning with the 
first noticeable change in the subject's usual condition. 
D. The episode of illness being considered does not meet the 
criteria for Panic Disorder, Major or Minor Depressive Disorder, 
Schizophrenia, Schizo-affective Disorders, Briquet's Disorder 
(Somatization Disorder), Intermittent Depressive Disorder, Labile 
Personality, Unspecified Functional Psychosis, or Manic Disorder, 
and was not limited to the two months prior to, or after these 
disorders. 
E. The episode of illness may be superimposed on another pre¬ 
existing psychiatric disorder, for example, Alcoholism, Phobic, 
or Obsessive/Compulsive Disorder. This category should be given 
as an additional diagnosis only if the anxious mood, by virtue of 
its intensity of effect on functioning, can be clearly 
distinguished from the subject's usual condition. 
F. When the episode of illness is not superimposed on another 
pre-existing psychiatric disorder, it must result in either 
impairment in functioning with family, at home, at work, or 
socially, taking medication, or seeking or being referred for 
help from someone. 
Obsessive/ Compulsive Disorder 
A through C are required. 
A. Has obsessions or compulsions which are defined as recurrent 
or persistent ideas, thoughts, images, feelings, impulses, or 
movements generally accompanied by a sense of subjective 
compulsion and a desire to resist the event and usually 
recognized by the individual as foreign to his personality or 
nature, i.e., "ego alien." 
B. The obsessions or compulsions, or reactions to them, have 
resulted in either impairment in functioning with family, at 
home, at school, at work, or socially, taking medication, or 
seeking or being referred for help from someone. 
C. The obsessive or compulsive symptoms do not coincide with an 
episode of probable or definite Major Depressive Disorder, 
Schizophrenia, Schizo-affective Disorders, not are they limited 
to a period of two months prior to, or two months after such an 
episode. 
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Phobic Disorder 
A through C are required for the episode of illness being 
considered. 
A. Persistent and recurring irrational fears of a specific 
object, activity, or situation which the subject tends to avoid. 
Usually the avoidance is recognized as unreasonable. In some 
cases, however, subjects with Phobic Disorder avoid situations 
because they anticipate overwhelming anxiety or some other strong 
emotion, and thereby claim their avoidance is rational. 
Irrational fears without a tendency to avoid specific situations 
are not phobias, e.g., most "cancer phobias." 
B. The phobic symptom(s), reactions to them, or behavior to 
avoid them has resulted in either impairment in functioning with 
family, at home, at school, at work, or socially, taking 
medication, or seeking or being referred for help from someone. 
C. The phobic symptoms are not limited to an episode of probable 
or definite Major Depressive Disorder, Schizophrenia, or Schizo¬ 
affective Disorders, nor are they limited to a period of two 
months prior to, or two months after such an episode. 
Subtypes of Phobic Disorder 
(1) Agoraphobia: Fear of leaving familiar setting of the home. 
Usually there are multiple fears including fears of traveling, 
crowds, closed spaces, stores, heights, with progressive 
restriction of activities. Usually associated with Panic 
Disorder. 
(2) Social phobias: Fears of situations involving other people 
not associated with leaving home. Most common are fears of 
public speaking, blushing, eating in public, writing in front of 
others, or using public lavatories. 
(3) Simple phobias: Single nonsocial phobias not associated with 
fear of leaving home. The most common are of animals, 
particularly reptiles, insects, and rodents. 
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